Omeros (OMER) Shares Issued (2011 - 2026)
Omeros (OMER) posted Shares Issued of $12.3 million for Q1 2026, down 32.87% sequentially from $18.3 million in Q4 2025, and up 77.78% YoY from $6.9 million in Q1 2025.
Omeros (OMER) Shares Issued (2011 - 2026) Analysis & Trends
Omeros has reported Shares Issued for 12 years, with the latest figure at $12.3 million in Q1 2026.
- Quarterly Shares Issued rose 77.78% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (up 77.78% YoY) and the FY2025 annual result came in at $18.3 million, up 9.48% from the prior year.
- Shares Issued declined to $12.3 million in Q1 2026 per OMER's latest filing, from $18.3 million in the prior quarter.
- Over five years, Shares Issued peaked at $19.5 million in Q3 2025 and troughed at $6.1 million in Q2 2024.
- A 5-year average of $13.2 million and a median of $13.3 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued tumbled 55.2% in 2024, then jumped 104.41% in 2025.
- Over 5 years, Shares Issued stood at $13.9 million in 2022, then advanced by 9.96% to $15.3 million in 2023, then advanced by 9.41% to $16.7 million in 2024, then advanced by 9.48% to $18.3 million in 2025, then plunged by 32.87% to $12.3 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $12.3 million, $18.3 million, and $19.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 16.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.22 Mn |
| Jun 30, 2026 | 16.22 Mn |
| Mar 31, 2026 | 12.27 Mn |
| Mar 31, 2026 | 12.27 Mn |
| Dec 31, 2025 | 18.27 Mn |
| Dec 31, 2025 | 18.27 Mn |
| Sep 30, 2025 | 19.47 Mn |
| Sep 30, 2025 | 19.47 Mn |
| Jun 30, 2025 | 12.47 Mn |
| Jun 30, 2025 | 12.47 Mn |
| Mar 31, 2025 | 6.90 Mn |
| Mar 31, 2025 | 6.90 Mn |
| Dec 31, 2024 | 16.69 Mn |
| Dec 31, 2024 | 16.69 Mn |
| Sep 30, 2024 | 18.13 Mn |
| Sep 30, 2024 | 18.13 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 10.97 Mn |
| Mar 31, 2024 | 10.97 Mn |